Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive Collies

P. E. Fassler From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by P. E. Fassler in
Current site
Google Scholar
PubMed
Close
 DVM
,
W. J. Tranquilli From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by W. J. Tranquilli in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
A. J. Paul From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by A. J. Paul in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
M. D. Soll From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by M. D. Soll in
Current site
Google Scholar
PubMed
Close
 MMedVet, BVSc
,
J. A. DiPietro From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by J. A. DiPietro in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
K. S. Todd From the Departments of Vererinary Parhobiology (Fassler, Paul, Todd) and Vererinary Clinical Medicine (Tranquilli, DiPierro), College of Vererinary Medicine, Universiry of Illinois, Urbana-Champaign 1008 W Hazelwood Dr, Urbana, IL 61801, and Merck Sharp & Dohme Research Laboratories, Rahway, NJ 07065-0914 (Soll).

Search for other papers by K. S. Todd in
Current site
Google Scholar
PubMed
Close
 PhD

Click on author name to view affiliation information

Summary

Twenty-four Collies sensitive to the toxic effects of ivermectin, when administered at high dosages, were studied to evaluate the effects of repeated monthly treatment with an ivermectin beef-based formulation at amounts up to 10 times the dosage recommended for heartworm prevention in dogs. Collies were treated 3 times at 30-day intervals at rates of 12, 36, or 60 μg of ivermectin/kg of body weight, or with vehicle. Complete physical and neurologic examinations were performed on all dogs prior to the first treatment and after the final treatment. Clinical observations and ivermectin reaction scores were recorded daily for each dog throughout the study.

Clinical or neurologic signs characteristic of ivermectin toxicosis were not observed for any dog during the study. Single episodes of vomiting were recorded for 2 vehicle-treated dogs and 2 dogs treated with ivermectin at 12 μg/kg from 6 to 21 days after treatment. At the end of the study, all dogs were challenge-exposed with ivermectin at 120 μg/kg to reconfirm their sensitivity to this class of compounds. All dogs developed signs typical of ivermectin toxicosis during the subsequent 48- to 72-hour period.

Results of this study demonstrated that ivermectin can be administered repeatedly without adverse effects at rates up to 60 μg/kg (10 times the recommended use level) to Collies known to be sensitive to this drug.

Summary

Twenty-four Collies sensitive to the toxic effects of ivermectin, when administered at high dosages, were studied to evaluate the effects of repeated monthly treatment with an ivermectin beef-based formulation at amounts up to 10 times the dosage recommended for heartworm prevention in dogs. Collies were treated 3 times at 30-day intervals at rates of 12, 36, or 60 μg of ivermectin/kg of body weight, or with vehicle. Complete physical and neurologic examinations were performed on all dogs prior to the first treatment and after the final treatment. Clinical observations and ivermectin reaction scores were recorded daily for each dog throughout the study.

Clinical or neurologic signs characteristic of ivermectin toxicosis were not observed for any dog during the study. Single episodes of vomiting were recorded for 2 vehicle-treated dogs and 2 dogs treated with ivermectin at 12 μg/kg from 6 to 21 days after treatment. At the end of the study, all dogs were challenge-exposed with ivermectin at 120 μg/kg to reconfirm their sensitivity to this class of compounds. All dogs developed signs typical of ivermectin toxicosis during the subsequent 48- to 72-hour period.

Results of this study demonstrated that ivermectin can be administered repeatedly without adverse effects at rates up to 60 μg/kg (10 times the recommended use level) to Collies known to be sensitive to this drug.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 397 397 158
PDF Downloads 60 60 7
Advertisement